EPISODE · Sep 11, 2026 · 11 MIN
中国药企2026年全球III期临床试验巡礼——从“单点突破”到“常态化出海” (Chinese-language podcast, Sept. 11, 2026)
from Scrip Podcasts · host Norstella
根据Citeline旗下Scrip在2026年9月4日发布的最新统计，截至今年8月底，已经有六个由中国药企作为唯一申办方且在美国招募患者的全球III期临床试验启动。这个节奏已经追平了2025年全年的总量。今天我们就把这六个临床试验挨个拆开来看，再聊聊这背后代表的行业信号。 Story link: https://insights.citeline.com/scrip/r-and-d/clinical-trials/chinese-firms-start-six-global-phase-iii-trials-with-us-sites-so-far-in-2026-7ZFDORUPSJGBDOCM2MFPDOPNT4/
Embed this episode
Ready to play
中国药企2026年全球III期临床试验巡礼——从“单点突破”到“常态化出海” (Chinese-language podcast, Sept. 11, 2026)
0:00
11:11
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Scrip Podcasts?
This episode is 11 minutes long.
When was this Scrip Podcasts episode published?
This episode was published on September 11, 2026.
Can I download this Scrip Podcasts episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!